Back to Journals » OncoTargets and Therapy » Volume 7

Outcomes analysis of an alternative formulation of PEGylated liposomal doxorubicin in recurrent epithelial ovarian carcinoma during the drug shortage era

Total article views   Abstract views HTML views PDF downloads Totals
6,834 Dovepress* 5,149 980+ 1,213 6,129
PubMed Central* 0 705 288 705
Totals 5,149 1,685 1,501 6,834
*Since 8 August 2014
+Since July 2016

View citations on PubMed Central and Google Scholar